San Carlos, CA, United States of America

Toni Chancellor

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Imago Biosciences, Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toni Chancellor. Retrieved from https://idiyas.com/inventor/toni-chancellor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Toni Chancellor

Introduction

Toni Chancellor is a notable inventor based in San Carlos, California. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for KDM1A. His work is characterized by a focus on innovative methods and processes that advance scientific understanding and therapeutic applications.

Latest Patents

Toni Chancellor holds one patent titled "Methods and processes for the preparation of KDM1A inhibitors." This patent discloses methods for the synthesis of substituted 2-arylcyclopropylamines and 2-heteroarylcyclopropylamines, along with related compounds. Additionally, it provides methods for the reduction of thioesters to aldehydes and methods for the reductive amination of cyclopropylamines. These advancements are crucial for developing new therapeutic strategies.

Career Highlights

Chancellor is currently associated with Imago Biosciences, Inc., where he applies his expertise in biochemistry to drive innovation. His work at the company reflects a commitment to advancing medical science through the development of novel compounds.

Collaborations

Some of his coworkers include Amy E. Tapper and Cassandra Celatka, who contribute to the collaborative environment at Imago Biosciences, Inc. Their combined efforts enhance the research and development initiatives within the company.

Conclusion

Toni Chancellor's innovative work in the field of biochemistry, particularly through his patent on KDM1A inhibitors, showcases his dedication to advancing medical science. His contributions are vital for the development of new therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…